Table 3.

Medicines where interrupted supply could result in serious health consequences – non-prescription medicines.

Pharmacists are required to limit dispensing of the below non-prescription medicines to one months' supply at the prescribed dose.
Medicines where interrupted supply could result in serious health consequences - non-prescription	Medicines that may be subject to increased demand due to COVID-19 symptom management - non-prescription
Adrenaline auto-injector	Anti-histamines
Chloramphenicol eye drops/ointment	Cough suppressants
Glyceryl trinitrate (GTN)	Decongestants
Levonorgestrel	Expectorants
Naloxone	Ibuprofen
Salbutamol	Mucolytics
	Aspirin
	Paracetamol
	Throat preparations (lozenges, gargles)

Adapted from the Limits on dispensing and sales of prescription and over-the-counter medicines, 2020, Therapeutic Goods Administration, used with permission of the Australian governmenthttps://www.tga.gov.au/media-release/limits-dispensing-and-sales-prescription-and-over-counter-medicines(Access data: 02/07/2020).